New transplant method tested for rare, Life-Threatening blood disease
NCT ID NCT06837987
Summary
This study looked back at the medical records of 72 patients with severe aplastic anemia, a rare and serious blood disease. The goal was to see if a modified stem cell transplant procedure and a specific anti-rejection drug plan were safe and effective. Researchers checked survival rates and complications over two years to see if this approach improved outcomes.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for APLASTIC ANAEMIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Department of Hematology，920th Hospital of Joint Logistics Support Force
Kunming, Yunnan, 650000, China
Conditions
Explore the condition pages connected to this study.